• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

二叶式主动脉瓣患者孤立性主动脉瓣感染性心内膜炎的特征与预后:一项倾向匹配研究

Characteristics and prognosis of isolated aortic valve infective endocarditis in patients with bicuspid aortic valves: a propensity matched study.

作者信息

Bohbot Yohann, Denev Seyhan, Benvenga Rossella M, Philip Mary, Michelena Hector I, Citro Rodolfo, Habib Gilbert, Tribouilloy Christophe

机构信息

Department of Cardiology, Amiens University Hospital, Amiens, France.

UR UPJV 7517, Jules Verne University of Picardie, Amiens, France.

出版信息

Front Cardiovasc Med. 2023 Dec 14;10:1304957. doi: 10.3389/fcvm.2023.1304957. eCollection 2023.

DOI:10.3389/fcvm.2023.1304957
PMID:38155986
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10753019/
Abstract

INTRODUCTION

Bicuspid aortic valve (BAV) is the most common congenital heart disease with an increased risk of infective endocarditis (IE). Few data are available on isolated native BAV-IE. The aim of this study was to compare patients with tricuspid aortic valve (TAV) IE and BAV-IE in terms of characteristics, management and prognosis.

MATERIAL AND METHODS

We included 728 consecutive patients with IE on isolated native aortic valve in 3 centres: Amiens and Marseille Hospitals in France and Salerno Hospital in Italy. We studied in hospital and long-term mortality before and after matching for age, sex and comorbidity index. Median follow-up was 67.2 [IQR: 19-120] months.

RESULTS

Of the 728 patients, 123 (16.9%) had BAV. Compared with patients with TAV-IE, patients with BAV-IE were younger, had fewer co-morbidities and were more likely to be male. They presented more major neurological events and perivalvular complications (both  < 0.05). Early surgery (<30 days) was performed in 52% of BAV-IE cases vs. 42.8% for TAV-IE ( = 0.061). The 10-year survival rate was 74 ± 5% in BAV-IE patients compared with 66 ± 2% in TAV-IE patients ( = 0.047). After propensity score matching (for age, gender and comorbidities), there was no difference in mortality between the two groups, with an estimated 10-year survival of 73 ± 5% vs. 76 ± 4% respectively ( = 0.91).

CONCLUSION

BAV is a frequent finding in patients with isolated aortic valve IE and is associated with more perivalvular complications and neurological events. The differences in survival with TAV-IE are probably related to the age and comorbidity differences between these two populations.

摘要

引言

二叶式主动脉瓣(BAV)是最常见的先天性心脏病,感染性心内膜炎(IE)风险增加。关于孤立性原发性BAV-IE的数据很少。本研究的目的是比较三尖瓣主动脉瓣(TAV)IE和BAV-IE患者在特征、治疗和预后方面的情况。

材料与方法

我们纳入了法国亚眠和马赛医院以及意大利萨勒诺医院3个中心连续收治的728例孤立性原发性主动脉瓣IE患者。我们研究了年龄、性别和合并症指数匹配前后的住院死亡率和长期死亡率。中位随访时间为67.2 [四分位间距:19 - 120]个月。

结果

在728例患者中,123例(16.9%)患有BAV。与TAV-IE患者相比,BAV-IE患者更年轻,合并症更少,且男性居多。他们出现更多的严重神经系统事件和瓣周并发症(均P < 0.05)。52%的BAV-IE病例进行了早期手术(<30天),而TAV-IE为42.8%(P = 0.061)。BAV-IE患者的10年生存率为74±5%,而TAV-IE患者为66±2%(P = 0.047)。在倾向评分匹配(年龄、性别和合并症)后,两组死亡率无差异,估计10年生存率分别为73±5%和76±4%(P = 0.91)。

结论

BAV在孤立性主动脉瓣IE患者中很常见,且与更多的瓣周并发症和神经系统事件相关。与TAV-IE患者生存率的差异可能与这两组人群的年龄和合并症差异有关。

相似文献

1
Characteristics and prognosis of isolated aortic valve infective endocarditis in patients with bicuspid aortic valves: a propensity matched study.二叶式主动脉瓣患者孤立性主动脉瓣感染性心内膜炎的特征与预后:一项倾向匹配研究
Front Cardiovasc Med. 2023 Dec 14;10:1304957. doi: 10.3389/fcvm.2023.1304957. eCollection 2023.
2
Aortic valve endocarditis in patients with bicuspid and tricuspid aortic valves.二叶式和三叶式主动脉瓣患者的主动脉瓣心内膜炎
JTCVS Open. 2021 Sep 15;8:228-236. doi: 10.1016/j.xjon.2021.09.007. eCollection 2021 Dec.
3
Infective endocarditis in patients with bicuspid aortic valve: Clinical characteristics, complications, and prognosis.二叶式主动脉瓣患者的感染性心内膜炎:临床特征、并发症及预后
Enferm Infecc Microbiol Clin. 2017 Dec;35(10):645-650. doi: 10.1016/j.eimc.2016.06.017. Epub 2016 Aug 1.
4
Risk and outcomes of aortic valve endocarditis among patients with bicuspid and tricuspid aortic valves.二叶式和三叶式主动脉瓣患者主动脉瓣心内膜炎的风险及预后
Open Heart. 2017 May 16;4(1):e000545. doi: 10.1136/openhrt-2016-000545. eCollection 2017.
5
Clinical characteristics and outcome of infective endocarditis in adults with bicuspid aortic valves: a multicentre observational study.成人二叶式主动脉瓣感染性心内膜炎的临床特征和转归:一项多中心观察性研究。
Heart. 2010 Nov;96(21):1723-9. doi: 10.1136/hrt.2009.189050. Epub 2010 May 16.
6
Clinical Characteristics and Surgical Treatment of Infective Endocarditis With Bicuspid Aortic Valve.二叶式主动脉瓣感染性心内膜炎的临床特征与外科治疗
Int Heart J. 2017 Apr 6;58(2):220-224. doi: 10.1536/ihj.16-284. Epub 2017 Mar 27.
7
Infective Endocarditis in Patients With Bicuspid Aortic Valves: Unique Clinical and Microbiologic Features.感染性心内膜炎患者的二叶主动脉瓣:独特的临床和微生物学特征。
Heart Lung Circ. 2024 Oct;33(10):1484-1491. doi: 10.1016/j.hlc.2024.02.023. Epub 2024 Aug 16.
8
Safety and efficacy of minimalist transcatheter aortic valve implantation using a new-generation balloon-expandable transcatheter heart valve in bicuspid and tricuspid aortic valves.使用新一代球囊扩张式经导管心脏瓣膜在二叶式和三叶式主动脉瓣中进行微创经导管主动脉瓣植入的安全性和有效性。
Clin Res Cardiol. 2021 Dec;110(12):1993-2006. doi: 10.1007/s00392-021-01935-7. Epub 2021 Sep 9.
9
Comparison Between Bicuspid and Tricuspid Aortic Regurgitation: Presentation, Survival, and Aorta Complications.二叶式与三叶式主动脉瓣反流的比较:临床表现、生存率及主动脉并发症
JACC Asia. 2022 Apr 2;2(4):476-486. doi: 10.1016/j.jacasi.2022.02.012. eCollection 2022 Aug.
10
Prevalence of permanent pacemaker implantation after conventional aortic valve replacement-a propensity-matched analysis in patients with a bicuspid or tricuspid aortic valve: a benchmark for transcatheter aortic valve replacement.传统主动脉瓣置换术后永久性起搏器植入的发生率——双叶或三叶主动脉瓣患者的倾向匹配分析:经导管主动脉瓣置换的一个基准
Eur J Cardiothorac Surg. 2020 Jul 1;58(1):130-137. doi: 10.1093/ejcts/ezaa053.

引用本文的文献

1
Bicuspid Aortic Valve and Sudden Cardiac Death.二叶式主动脉瓣与心源性猝死
Life (Basel). 2025 May 28;15(6):868. doi: 10.3390/life15060868.
2
Recurrent Systemic Embolization From Bicuspid Aortic Valve Endocarditis in the Setting of Anti-coagulation Use.抗凝治疗情况下二叶式主动脉瓣心内膜炎所致复发性系统性栓塞
Cureus. 2024 Nov 7;16(11):e73187. doi: 10.7759/cureus.73187. eCollection 2024 Nov.

本文引用的文献

1
2023 ESC Guidelines for the management of endocarditis.2023年欧洲心脏病学会感染性心内膜炎管理指南。
Eur Heart J. 2023 Oct 14;44(39):3948-4042. doi: 10.1093/eurheartj/ehad193.
2
Clinical Outcomes of Adults With Bicuspid Aortic Valve: A European Perspective.成人二叶式主动脉瓣的临床转归:欧洲视角。
Mayo Clin Proc. 2021 Mar;96(3):648-657. doi: 10.1016/j.mayocp.2020.04.047.
3
Outcome of Normal-Flow Low-Gradient Severe Aortic Stenosis With Preserved Left Ventricular Ejection Fraction: A Propensity-Matched Study.正常血流低梯度重度主动脉瓣狭窄伴左心室射血分数保留患者的转归:一项倾向评分匹配研究。
J Am Heart Assoc. 2019 Oct;8(19):e012301. doi: 10.1161/JAHA.119.012301. Epub 2019 Sep 25.
4
Incidence of Infective Endocarditis in Patients With Bicuspid Aortic Valves in the Community.社区中患有二叶式主动脉瓣患者感染性心内膜炎的发病率。
Mayo Clin Proc. 2016 Jan;91(1):122-3. doi: 10.1016/j.mayocp.2015.10.011.
5
Bicuspid aortic valve: identifying knowledge gaps and rising to the challenge from the International Bicuspid Aortic Valve Consortium (BAVCon).二叶式主动脉瓣:识别知识空白并应对来自国际二叶式主动脉瓣联盟(BAVCon)的挑战。
Circulation. 2014 Jun 24;129(25):2691-704. doi: 10.1161/CIRCULATIONAHA.113.007851.
6
Clinical characteristics and outcome of infective endocarditis in adults with bicuspid aortic valves: a multicentre observational study.成人二叶式主动脉瓣感染性心内膜炎的临床特征和转归:一项多中心观察性研究。
Heart. 2010 Nov;96(21):1723-9. doi: 10.1136/hrt.2009.189050. Epub 2010 May 16.
7
Risk of embolism and death in infective endocarditis: prognostic value of echocardiography: a prospective multicenter study.感染性心内膜炎的栓塞和死亡风险:超声心动图的预后价值:一项前瞻性多中心研究
Circulation. 2005 Jul 5;112(1):69-75. doi: 10.1161/CIRCULATIONAHA.104.493155. Epub 2005 Jun 27.
8
Bicuspid aortic valve--A silent danger: analysis of 50 cases of infective endocarditis.二叶式主动脉瓣——一种隐匿的危险:50例感染性心内膜炎分析
Clin Infect Dis. 2000 Feb;30(2):336-41. doi: 10.1086/313646.
9
Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group.倾向得分法在治疗组与非随机对照组比较中减少偏倚的应用
Stat Med. 1998 Oct 15;17(19):2265-81. doi: 10.1002/(sici)1097-0258(19981015)17:19<2265::aid-sim918>3.0.co;2-b.